Deep Brain Stimulation Tied to Lower Mortality in PD

Deep Brain Stimulation Tied to Lower Mortality in PD

Publication date: Jul 09, 2026

The non-DBS cohort included many patients hospitalized for acute medical illness, whereas patients selected for DBS are generally healthier and have fewer surgical contraindications. Disclosure information for the study investigators is available in the original study publication. This article was created using several editorial tools, including AI, as part of the process. It was published online on June 24 in npj Parkinsons Disease. LIMITATIONSThe study was limited by a retrospective observational design. Residual confounding, code-based misclassification, and the lack of PD-specific clinical measures may have influenced the results. Human editors reviewed this content before publication.

Concepts Keywords
Hospitalization Brain
Japan Care
June Clinical
Skilled Costs
Dbs
Group
Healthcare
Institutionalization
Long
Lower
Mortality
Non
Parkinsons
Term
Years

Semantics

Type Source Name
disease MESH included
drug DRUGBANK Tropicamide
disease MESH death
disease MESH DBS

(Visited 41 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *